Skip to main content
. 2018 Jan 10;12:793. doi: 10.3332/ecancer.2018.793

Table 2. Inclusion criteria for TARGIT-A trial.

Age ≥45 years
Invasive breast cancers other than lobular
T1 and T2 (<3.5 cm), N0-1, M0
  • Suitable for breast conserving surgery

  • Available for follow-up for at least ten years

Previously diagnosed and treated contralateral breast cancer